login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
BOUNDLESS BIO INC (BOLD) Stock News
NASDAQ:BOLD - Nasdaq -
US10170A1007
-
Common Stock
- Currency: USD
1.21
+0.03 (+2.54%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
BOLD Latest News, Press Relases and Analysis
All
Press Releases
2 months ago - By: Boundless Bio, Inc.
Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
2 months ago - By: Boundless Bio, Inc.
Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
2 months ago - By: Boundless Bio, Inc.
Boundless Bio Announces Portfolio Prioritization and Runway Extension
2 months ago - By: Boundless Bio, Inc.
Boundless Bio Announces Portfolio Prioritization and Runway Extension
a year ago - By: BusinessInsider
BOLD Stock Earnings: Boundless Bio Beats EPS for Q2 2024
a year ago - By: InvestorPlace
BOLD Stock Earnings: Boundless Bio Beats EPS for Q2 2024
a year ago - By: InvestorPlace
BOLD Stock Earnings: Boundless Bio Reported Results for Q1 2024
2 months ago - By: Zacks Investment Research
Boundless Bio, Inc. (BOLD) Upgraded to Buy: Here's What You Should Know
2 months ago - By: Boundless Bio, Inc.
Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights
2 months ago - By: Boundless Bio, Inc.
Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights
4 months ago - By: Boundless Bio, Inc.
Boundless Bio to Participate in the Needham Virtual Healthcare Conference
4 months ago - By: Boundless Bio, Inc.
Boundless Bio to Participate in the Needham Virtual Healthcare Conference
4 months ago - By: Boundless Bio, Inc.
Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
4 months ago - By: Boundless Bio, Inc.
Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
5 months ago - By: Boundless Bio, Inc.
Boundless Bio to Participate in the Leerink Global Healthcare Conference
6 months ago - By: Boundless Bio, Inc.
Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer
6 months ago - By: Boundless Bio, Inc.
Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer
7 months ago - By: Boundless Bio, Inc.
Boundless Bio Announces Pipeline and Leadership Updates
7 months ago - By: Boundless Bio, Inc.
Boundless Bio Announces Pipeline and Leadership Updates
8 months ago - By: Boundless Bio, Inc.
Boundless Bio to Participate in the Piper Sandler Healthcare Conference
8 months ago - By: Boundless Bio, Inc.
Boundless Bio to Participate in the Piper Sandler Healthcare Conference
9 months ago - By: Boundless Bio, Inc.
Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights
9 months ago - By: Boundless Bio, Inc.
Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights
9 months ago - By: Boundless Bio, Inc.
Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference
9 months ago - By: Boundless Bio, Inc.
Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference
9 months ago - By: Boundless Bio, Inc.
Boundless Bio Announces Departure of Chief Financial Officer
9 months ago - By: Boundless Bio, Inc.
Boundless Bio Announces Departure of Chief Financial Officer
10 months ago - By: Boundless Bio, Inc.
Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference
10 months ago - By: Boundless Bio, Inc.
Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference
a year ago - By: Boundless Bio, Inc.
Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results
a year ago - By: Boundless Bio, Inc.
Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results
a year ago - By: Boundless Bio
Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
a year ago - By: Boundless Bio
Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights
a year ago - By: Boundless Bio
Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024
a year ago - By: Boundless Bio
Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications
a year ago - By: Boundless Bio
Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024
Please enable JavaScript to continue using this application.